Isomorphic Labs talks $40B valuation five months after $2.1B round

Bloomberg says Isomorphic Labs' early funding talks could value it as high as $50B, though terms could change.

By · Published

Isomorphic Labs discusses a $40B valuation five months after its $2.1B round — Demis Hassabis founded the Alphabet-backed drug-discovery company around AlphaFold's promise; Bloomberg reports the new financing talks are early and terms…

Bloomberg says Isomorphic Labs' early funding talks could value it as high as $50B, though terms could change.